Potassium Citrate Tablet, Extended Release
Product Images NDC 71335-2897

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 71335-2897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

FDA Label Image

Table 1. (Table 1.)

This information shows the effect of Potassium Citrate on patients with Calcium Oxalate Nephrolithiasis, measured by the number of stones formed per year. The table displays data for different groups and illustrates the reduction in stone formation after treatment. The percentage of patients achieving remission, defined as remaining free of newly formed stones during treatment, is also included.*

FDA Label Image

Label (Lbl713352897)

This is a package insert for Potassium Citrate Extended-Release Tablets. Each tablet contains 15 mEq of Potassium Citrate and is oval-shaped, uncoated, and off-white to tan yellowish in color. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It is advised to keep this medication out of the reach of children and dispense it in a tight container with a child-resistant closure.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.